---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-028406"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T23:09:52.713842+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth Q2 net sales $117.5M (+13% YoY); net income $3.4M; reaffirms FY guidance

## Summary
- Net sales $117.5M (+13% YoY); net income $3.4M; adjusted EBITDA margin 15.1%.
- Reaffirms 2023 net sales and 2025 guidance; refines 2023 adj. EBITDA margin to 18%-19%.
- Consumables net sales +34% YoY; delivery systems +1% (or +30% ex trade-ups).
- APAC net sales +143% YoY (China +265%); partner LaserAway for Syndeo at 125+ locations.
- FDA clearance for SkinStylus for facial acne scarring; AWS collaboration for generative AI.

## SEC filing metadata
- accession: 0001628280-23-028406
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828023028406/0001628280-23-028406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828023028406/skin-20230809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-028406
- JSON: https://secwatch.observer/filing/0001628280-23-028406.json
- Plain text: https://secwatch.observer/filing/0001628280-23-028406.txt

## Key facts
- Earnings Releases
  SkinHealth Systems Inc. reported the second quarter ended June 30, 2023 results: revenue $117.5 million, net income $3.4 million. Guidance reaffirmed.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $117.5 million
  - Net income: $3.4 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: For the quarter, net sales of $117.5 million increased +13% year-over-year, or +32% excluding trade-ups, continuing a trend of double-digit quarterly growth. Net income was $3.4 million, and adjusted EBITDA margin was 15.1% for the quarter. On the momentum, the Company re-affirms its 2023 net sales and long-term 2025 financial guidance, and refines its 2023 adjusted EBITDA margin to a more precise 18%-19% range.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023028406/0001628280-23-028406-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.